All Patients N=100 | Solumbra group N=55 (%) | ADAPT group N=45 (%) | p Value* | |
---|---|---|---|---|
Mean number of device passes | 2.7 | 2.2 | 3.3† | 0.02 |
IA-tPA administration | 8 | 5 (9) | 3 (7) | 0.7 |
Glycoprotein IIb/IIIa inhibitor administration | 6 | 4 (7) | 2 (4) | 0.7 |
Successful reperfusion (TICI 2b/3) | 86 | 46 (84) | 40 (89) | 0.6 |
Mean time from puncture to reperfusion, min | 51 | 51 | 50 | 0.8 |
Mean time from LKW to reperfusion, min | 299 | 319 | 274 | 0.08 |
Carotid stent deployment | 11 | 5 (9) | 6 (13) | 0.5 |
Embolus to uninvolved territory | 3 | 1 (2) | 2 (4) | 0.6 |
Cervical dissection | 2 | 0 | 2 (4) | 0.2 |
Catheter rupture and retention | 1 | 0 | 1 (2) | 0.5 |
Vessel rupture | 1 | 1 (2) | 0 | 1 |
Bold type indicates statistical significance.
*p Value for the difference between the Solumbra group and the ADAPT group using either the Student t test or Fisher exact test.
†Includes total number of ADAPT and Solumbra passes in cases where Solumbra salvage was needed.
ADAPT, A Direct Aspiration first-Pass Thrombectomy; IA-tPA, intra-arterial tissue plasminogen activator; LKW, last known well; N, number of patients; TICI, Thrombolysis In Cerebral Infarction.